175 related articles for article (PubMed ID: 33013319)
1. Development and Validation of CRISPR Activator Systems for Overexpression of CB1 Receptors in Neurons.
Di Maria V; Moindrot M; Ryde M; Bono A; Quintino L; Ledri M
Front Mol Neurosci; 2020; 13():168. PubMed ID: 33013319
[TBL] [Abstract][Full Text] [Related]
2. Programmable activation of Bombyx gene expression using CRISPR/dCas9 fusion systems.
Wang XG; Ma SY; Chang JS; Shi R; Wang RL; Zhao P; Xia QY
Insect Sci; 2019 Dec; 26(6):983-990. PubMed ID: 30088341
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of dCas9-VP64 variants and multiplexed guide RNAs mediating CRISPR activation.
Omachi K; Miner JH
PLoS One; 2022; 17(6):e0270008. PubMed ID: 35763517
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional manipulation of gene expression in adipocytes using CRISPRa and siRNA.
Lundh M; Pluciñska K; Isidor MS; Petersen PSS; Emanuelli B
Mol Metab; 2017 Oct; 6(10):1313-1320. PubMed ID: 29031730
[TBL] [Abstract][Full Text] [Related]
5. Optimized strategy for in vivo Cas9-activation in
Ewen-Campen B; Yang-Zhou D; Fernandes VR; González DP; Liu LP; Tao R; Ren X; Sun J; Hu Y; Zirin J; Mohr SE; Ni JQ; Perrimon N
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):9409-9414. PubMed ID: 28808002
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Transcriptional Activation Using CRISPR/Cas9 in Drosophila.
Lin S; Ewen-Campen B; Ni X; Housden BE; Perrimon N
Genetics; 2015 Oct; 201(2):433-42. PubMed ID: 26245833
[TBL] [Abstract][Full Text] [Related]
7. A Self-Deleting AAV-CRISPR System for
Li A; Lee CM; Hurley AE; Jarrett KE; De Giorgi M; Lu W; Balderrama KS; Doerfler AM; Deshmukh H; Ray A; Bao G; Lagor WR
Mol Ther Methods Clin Dev; 2019 Mar; 12():111-122. PubMed ID: 30619914
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient activation of endogenous gene in grape using CRISPR/dCas9-based transcriptional activators.
Ren C; Li H; Liu Y; Li S; Liang Z
Hortic Res; 2022 Jan; 9():. PubMed ID: 35039855
[TBL] [Abstract][Full Text] [Related]
9. A Simple Cloning-free Method to Efficiently Induce Gene Expression Using CRISPR/Cas9.
Fang L; Hung SSC; Yek J; El Wazan L; Nguyen T; Khan S; Lim SY; Hewitt AW; Wong RCB
Mol Ther Nucleic Acids; 2019 Mar; 14():184-191. PubMed ID: 30594894
[TBL] [Abstract][Full Text] [Related]
10. CRISPR technologies for stem cell engineering and regenerative medicine.
Hsu MN; Chang YH; Truong VA; Lai PL; Nguyen TKN; Hu YC
Biotechnol Adv; 2019 Dec; 37(8):107447. PubMed ID: 31513841
[TBL] [Abstract][Full Text] [Related]
11. Next-generation CRISPR/Cas9 transcriptional activation in
Jia Y; Xu RG; Ren X; Ewen-Campen B; Rajakumar R; Zirin J; Yang-Zhou D; Zhu R; Wang F; Mao D; Peng P; Qiao HH; Wang X; Liu LP; Xu B; Ji JY; Liu Q; Sun J; Perrimon N; Ni JQ
Proc Natl Acad Sci U S A; 2018 May; 115(18):4719-4724. PubMed ID: 29666231
[TBL] [Abstract][Full Text] [Related]
12. All-in-one AAV-delivered epigenome-editing platform:
Kantor B; Odonovan B; Rittiner J; Hodgson D; Lindner N; Guerrero S; Dong W; Zhang A; Chiba-Falek O
bioRxiv; 2024 May; ():. PubMed ID: 38798630
[TBL] [Abstract][Full Text] [Related]
13. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
[TBL] [Abstract][Full Text] [Related]
14. Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission.
Peng C; Yan Y; Kim VJ; Engle SE; Berry JN; McIntosh JM; Neve RL; Drenan RM
Eur J Neurosci; 2019 Aug; 50(3):2224-2238. PubMed ID: 29779223
[TBL] [Abstract][Full Text] [Related]
15. A gene therapy for inherited blindness using dCas9-VPR-mediated transcriptional activation.
Böhm S; Splith V; Riedmayr LM; Rötzer RD; Gasparoni G; Nordström KJV; Wagner JE; Hinrichsmeyer KS; Walter J; Wahl-Schott C; Fenske S; Biel M; Michalakis S; Becirovic E
Sci Adv; 2020 Aug; 6(34):eaba5614. PubMed ID: 32875106
[TBL] [Abstract][Full Text] [Related]
16. Robust Transcriptional Activation in Plants Using Multiplexed CRISPR-Act2.0 and mTALE-Act Systems.
Lowder LG; Zhou J; Zhang Y; Malzahn A; Zhong Z; Hsieh TF; Voytas DF; Zhang Y; Qi Y
Mol Plant; 2018 Feb; 11(2):245-256. PubMed ID: 29197638
[TBL] [Abstract][Full Text] [Related]
17. Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRa.
Lau CH; Ho JW; Lo PK; Tin C
Mol Ther Nucleic Acids; 2019 Jun; 16():637-649. PubMed ID: 31108320
[TBL] [Abstract][Full Text] [Related]
18. RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis.
Park JJ; Dempewolf E; Zhang W; Wang ZY
PLoS One; 2017; 12(6):e0179410. PubMed ID: 28622347
[TBL] [Abstract][Full Text] [Related]
19. Highly efficient Cas9-mediated transcriptional programming.
Chavez A; Scheiman J; Vora S; Pruitt BW; Tuttle M; P R Iyer E; Lin S; Kiani S; Guzman CD; Wiegand DJ; Ter-Ovanesyan D; Braff JL; Davidsohn N; Housden BE; Perrimon N; Weiss R; Aach J; Collins JJ; Church GM
Nat Methods; 2015 Apr; 12(4):326-8. PubMed ID: 25730490
[TBL] [Abstract][Full Text] [Related]
20. Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells.
Javaid N; Pham TLH; Choi S
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
